Cargando…
PD-L1 expression on peripheral T-cells and association with coronary heart disease patients: A protocol for systematic reviews and meta-analysis
BACKGROUND: As immune checkpoint pathways, programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) can be exploited by tumor cells to evade immuno-surveillance. Inflammation and immune processes play decisive roles in the occurrence and development of coronary heart disease (CHD). The low ex...
Autores principales: | Zhang, Chunwei, Yang, Ke, Yang, Ying, Zhao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282099/ https://www.ncbi.nlm.nih.gov/pubmed/33761687 http://dx.doi.org/10.1097/MD.0000000000025157 |
Ejemplares similares
-
Efficacy and safety of Zhibitai in treating coronary heart disease patients with hyperlipemia: A protocol for systematic review and meta-analysis
por: Chen, Mingtai, et al.
Publicado: (2020) -
Cardiac adverse events of PD-1 and PD-L1 inhibitors in cancer protocol for a systematic review and network meta-analysis: A protocol for systematic review
por: Han, Deting, et al.
Publicado: (2020) -
Altered Expression of TXNIP in the peripheral leukocytes of patients with coronary atherosclerotic heart disease
por: Zhang, Yujing, et al.
Publicado: (2017) -
Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Liu, Shengxiang, et al.
Publicado: (2021) -
Efficacy and safety of Xinkeshu in the treatment of angina pectoris of coronary heart disease: A protocol for systematic review and meta-analysis
por: Fan, Maoxia, et al.
Publicado: (2021)